Top stocks in focus today: Fortis, Lupin, Indian Hume Pipe, Vedanta, Andhra Bank
Fortis Healthcare receives non-binding expression of interest from Fosun.
Lupin receives tentative USFDA approval for generic AndroGel.
Indian Hume Pipe Company Ltd receives order of Rs108.19cr.
Shalby signs memorandum of understanding with Sen Sok International University Hospital, Cambodia.
Indian Hotels enters Saudi with first Taj hotel in Makkah.
NHPC’s 50 MW solar project synced with grid, as per media reports.
Ducon gets final NCLT order approving ongoing merger process.
Jayaswal Neco Industries says SC directed parties involved in debt restructuring of company to maintain status quo.
AstraZeneca to invest $90mn over the next 5 years in India.
Vedanta’s resolution plan for Electrosteel Steels approved by NCLT.
KS Oils says corporate insolvency resolution process expired on April 16. The committee of creditors has not approved resolutions plans.
Andhra Bank says exposure to SSK Trading of Rs30cr is non-performing asset (Bloomberg).
HAL enhances jet production capacity (Bloomberg).
Jagran Prakashan to consider share buyback on April 27.
Uttam Galva says lenders yet to accept offer to settle debt.
Future Consumer hikes stake in Integrated Food Park Pvt. Ltd. to 99.93%.